EU Biotech Act Archives - hollandbio

Hollandbio asks for more impact in Biotech Act Part I

Dina Diek — Tue, 01 Sep 2026 12:36:05 +0000

The EU Biotech Act offers Europe a unique opportunity to strengthen its position as a global biotech leader. To help ensure the Act delivers on that promise, hollandbio submitted feedback this summer on Part I of the Act to the European Commission. We believe Europe is right to recognise biotech as a strategic technology for […]

The post Hollandbio asks for more impact in Biotech Act Part I appeared first on hollandbio.

Europe’s biotech future is up for debate

Dina Diek — Tue, 07 Jul 2026 13:17:06 +0000

Brussels will soon head into the summer break, but the debate on Europe’s biotech future is far from slowing down. Across Europe, policymakers are increasingly recognizing biotech as a strategic priority for competitiveness, resilience and economic growth. As Europe faces growing competition from the US and China for biotech investment, talent and manufacturing, it is […]

The post Europe’s biotech future is up for debate appeared first on hollandbio.

Hollandbio submits input for the EU Biotech Act II

Idalia Dlugosz — Tue, 16 Jun 2026 08:47:49 +0000

Last week, hollandbio submitted its input to the European Commission’s (now closed) Call for Evidence on the EU Biotech Act II — a key opportunity for shaping the future of biotechnology and biomanufacturing in Europe. Together with partners across the ecosystem, we provided detailed and concrete suggestions on how to address the key challenges the […]

The post Hollandbio submits input for the EU Biotech Act II appeared first on hollandbio.

Help Europe lead the wave in biotech innovation

Dina Diek — Tue, 19 May 2026 13:08:03 +0000

The Call for Evidence on Biotech Act II is now open (deadline June 10th): a crucial opportunity for input the European biotech sector cannot afford to miss. With this next phase, the European Commission is focusing on industrial biotechnology and biomanufacturing, aiming to address bottlenecks such as insufficient market uptake, investment predictability and timelines, and […]

The post Help Europe lead the wave in biotech innovation appeared first on hollandbio.

MEPs join biotech sector to urge moving forward with Biotech Act II

Idalia Dlugosz — Tue, 21 Apr 2026 12:23:18 +0000

Members of the European Parliament are joining forces with the biotech sector to urge the European Commission to move forward with the promised Biotech Act II – echoing earlier calls from biotech actors to act now. In a letter sent to Executive Vice President Stéphane Séjourné, lawmakers and the European Biosolutions Coalition stress that Biotech […]

The post MEPs join biotech sector to urge moving forward with Biotech Act II appeared first on hollandbio.

Nederland en Denemarken pleiten voor ambitieuze Biotech Act II

Idalia Dlugosz — Tue, 31 Mar 2026 14:17:23 +0000

Nederland en Denemarken zetten vaart achter een sterke Europese biotechagenda. Tijdens de EU‑Raad voor Concurrentievermogen eind februari riepen zij de Europese Commissie gezamenlijk op om te komen met een ambitieuze Biotech Act II die logisch voortbouwt op de recent gepresenteerde Biotech Act I. Met een krachtige non‑paper brachten zij deze oproep onder de aandacht van […]

The post Nederland en Denemarken pleiten voor ambitieuze Biotech Act II appeared first on hollandbio.

Biotech beleidsmakers en bedrijven op bezoek bij hollandbio

Idalia Dlugosz — Tue, 31 Mar 2026 14:15:17 +0000

Vorige week bracht hollandbio beleidsmakers en biotechbedrijven samen om tijdens een Lunch & Learn te praten over de toekomst van biotech in Nederland en Europa. In de zaal zaten vertegenwoordigers van ministeries die werken aan de nationale biotechvisie en de Europese Biotech Act, RVO en Invest-NL, én bedrijven uit medische, voeding- en industriële biotech. Samen […]

The post Biotech beleidsmakers en bedrijven op bezoek bij hollandbio appeared first on hollandbio.

Dutch assessment of the EU Biotech Act: no guts no glory?

Idalia Dlugosz — Tue, 24 Mar 2026 15:10:10 +0000

In December 2025, the European Commission unveiled Part I of the EU Biotech Act, a long-awaited signal that Europe aims to unlock biotech’s full potential. During the holidays, the Dutch government dove into the EU proposals to draft its assessment, a so-called BNC-fiche. And, as the Netherlands does not shy away from communicating its strong ambition […]

The post Dutch assessment of the EU Biotech Act: no guts no glory? appeared first on hollandbio.

European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem

Idalia Dlugosz — Tue, 17 Feb 2026 13:45:39 +0000

Europe accounts for just 7% of global life sciences Venture Capital (VC), and 66 of 67 EU biotech IPOs in the past six years have been listed outside the EU. Europe is failing to scale life science innovation, held back by fragmented capital markets and structural investment barriers. Reason enough for a group of leading […]

The post European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem appeared first on hollandbio.

Strategische prioriteit biotech lijkt steeds vaker tot financieringsmogelijkheden te leiden

Dina Diek — Tue, 03 Feb 2026 11:10:01 +0000

Biotech staat duidelijk op de kaart. De sector is aangewezen als een van de tien sleuteltechnologieën binnen de Nationale Technologiestrategie (NTS), als een van de zes specifieke markten in het aangekondigde Industriebeleid met focus, als een van de vier focusdomeinen in het rapport-Wennink én als een van de vier strategische technologieën van het Europese Competitiveness […]

The post Strategische prioriteit biotech lijkt steeds vaker tot financieringsmogelijkheden te leiden appeared first on hollandbio.